Olinding, Lolita M.
HRN: 05-06-48 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/16/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/16/2022
06/23/2022
IV
4.5gram
Q6hrs
Septic; S/P Hip Disarticulation, Left
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueUnspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes